Dynavax Technologies to Report First Quarter 2019 Financial Results and Host Conference Call on May 8

NEXT STORY
Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
PREV STORY
Agios to Webcast Conference Call of First Quarter 2019 Financial Results on May 2, 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Glycomics/Glycobiology Market Size to Reach USD 2.88 Billion in 2028; rising demand for precision medicine are some other key factors expected to drive market revenue growth over the forecast period, Says Reports And Data

author_avatar
NASDAQ Market News

Data from Codiak’s exoSTING™ Preclinical Development Program for the Treatment of Solid Tumors Published in the Nature Research Publication, Communications Biology

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Establishing European Subsidiary; CEO Increases Equity Stake in IPIX

BEVERLY, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News